Abstract
A small proportion of radiopharmaceutical administrations are extravasted from the injection site to the surrounding tissue. Of interest is the resulting absorbed dose. This investigation was undertaken to determine the biologic behavior and subsequent dosimetry of selected radiopharmaceutical infiltrations using a rat model. Subcutaneous injection of 99mTc-microspheres, 99mTc-MDP, 67Gacitrate, and 201Tl-chloride were studied. Three adult male Sprague-Dawley rats were injected subcutaneously at three seperate sites on the shaven backs of the animals for each agent studied (i.e., nine sites per agent). The rats were imaged and the resulting data were analyzed by computer immediately after injection and at various intervals up to 5–6 h, and again at 24 h. Particulate subcutaneous 99mTc-microspheres exhibit essentially no diffusion of tracer from the injection site, whereas non particulates showed a biexponential release pattern. Radiation burdens in rad/mCi (mGy/MBq) due to an infiltrate volume uniformally distributed over a 5 g mass for 99mTc-microspheres, 99mTc-MDP, 67Ga-citrate and 201Tl-chloride were 59.4(16.0), 13.6(3.7), 32.9(8.9) and 92.2(24.9), respectively. The radiobiological risk associated with these radiation burdens are below that needed to produce severe skin reactions when distributed within a 5 g mass.
Similar content being viewed by others
References
Alavi A, Staum M, Shesol BF, Bloch PH (1978) Technetium-99m Stannous Phytate as an Imaging Agent for Lymph Nodes. J Nucl Med 19:422–426
Allen KDA, Treed TW (1956) Skin cancer: Correlation of field size and cancerocidal dose in roentgen treatment. Am J Roentgen 75:581–589
Blaufox MD, Freuman LM (1978) Physicians desk reference for radiology and nuclear medicine, 1978/9, Table C, Radiation dose from commonly performed imaging procedure, P. 100, Medical Economics Company, Oradell, NJ
Dillman LT, Vanderlage FC (1975) Radionuclide Decay Schemes and Nuclear Parameters for Use in Radiation — Dose Estimation. MIRD Pamphlet No. 10, Soc Nucl Med
Kalz F (1941) Theoretical considerations and clinical of Grenz rays in dermatology. Arch Derm Symp 43:447–472
Kaplan WD, Piez CW, Gelman RS, Laffin SM, Rosenbaum EM, Jennings CA, McCormick CA, Harris JR, Henderson IC, Alsins HL (1985) Clinical comparison of two radiocolloids for internal mammary lymphoscintigraphy. J Nucl Med 26:1382–1385
Kereiakes JG, Feller PA, Ascoli FA, Thomas SR, Gelfand MJ, Saenger EL (1976) Pediatric radiopharmaceutical dosimetry. In: Radiopharmaceutical Dosimetry Symposium, Proceedings, of Conference Helda t Oak Ridge, TN, April 26–29, HEW Pub. (FDA) 76-8044, pp 77–91
Low-Beer BU (1946) External Use of Radioactive Phosphorous; Erythema Studies. Radiology 47:213–222
Mettler FA Jr, Moseley RD, Jr (1985) Direct effects of radiation, Medical Effects of Ionizing Radiation. Grune and Stratton, New York, 126–191
NCRP Report No. 39 (1971) Basic Radiation Protection Criteria, January 15, NCRP Publications, Box 4867, Washington, DC 2008, p 49
Pattan HS, Illar RG (1950) Accidental skin ulceration from radioisotopes. JAMA 143:554–559
Piers DA, Beekhuis H (1987) Local radiation dose from extravasal Tl-201. J Nucl Med 28:684
Shapiro B, Pillay M, Cox PH (1987) Dosimetric consequences of interstitial extravasations following IV administration of a radiopharmaceutical. Eur J Nucl Med 12:522–523
Snyder WS, Ford MR, Warner GG, Watson SB (1975) “S” absorbed dose per unit cumulated activity for selected radionuclides and organs. MIRD Pamphlet No. 11, Soc Nucl Med
Wolf R (1968) Radiation exposure of a patient in routine clinical scintigraphic investigations in medical radioisotope scientigraphy, Vol I, IAEA, STJ/PUB/103, Vienna, pp 829–841
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Castronovo, F.P., McKusick, K.A. & Strauss, H.W. The infiltrated radiopharmaceutical injection: Dosimetric considerations. Eur J Nucl Med 14, 93–97 (1988). https://doi.org/10.1007/BF00253448
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF00253448